author keywords: anticoagulant; canine; thromboprophylaxis; venous thrombosis

MeSH headings : Animals; Anticoagulants; Clopidogrel / therapeutic use; Dog Diseases / drug therapy; Dogs; Factor Xa Inhibitors / therapeutic use; Humans; Retrospective Studies; Rivaroxaban / therapeutic use; Thrombosis / drug therapy; Thrombosis / veterinary

TL;DR: Dogs in this study received a range of rivaroxaban dosages and attained variable aXa values that were not directly correlated with dosage and there were also no significant differences in baseline clinicopathological variables in dogs in which a Xa fell within or outside this range. (via Semantic Scholar)